Ontology highlight
ABSTRACT: Purpose
To use a previously developed CoMFA model to design a series of new structures of high selectivity and efficacy towards the beta(2)-adrenergic receptor.Results
Out of 21 computationally designed structures 6 compounds were synthesized and characterized for beta(2)-AR binding affinities, subtype selectivities and functional activities.Conclusion
the best compound is (R,R)-4-methoxy-1-naphthylfelnoterol with K(i)beta(2)-AR=0.28microm, K(i)beta(1)-AR/K(i)beta(2)-AR=573, EC(50cAMP)=3.9nm, EC(50cardio)=16nm. The CoMFA model appears to be an effective predictor of the cardiomocyte contractility of the studied compounds which are targeted for use in congestive heart failure.
SUBMITTER: Jozwiak K
PROVIDER: S-EPMC2832585 | biostudies-literature | 2010 Jan
REPOSITORIES: biostudies-literature
Jozwiak Krzysztof K Woo Anthony Yiu-Ho AY Tanga Mary J MJ Toll Lawrence L Jimenez Lucita L Kozocas Joseph A JA Plazinska Anita A Xiao Rui-Ping RP Wainer Irving W IW
Bioorganic & medicinal chemistry 20091206 2
<h4>Purpose</h4>To use a previously developed CoMFA model to design a series of new structures of high selectivity and efficacy towards the beta(2)-adrenergic receptor.<h4>Results</h4>Out of 21 computationally designed structures 6 compounds were synthesized and characterized for beta(2)-AR binding affinities, subtype selectivities and functional activities.<h4>Conclusion</h4>the best compound is (R,R)-4-methoxy-1-naphthylfelnoterol with K(i)beta(2)-AR=0.28microm, K(i)beta(1)-AR/K(i)beta(2)-AR=5 ...[more]